Domestic and International Exchange Dynamics-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Professor Xu Yi from Yinfeng Cryomedicine Expert Committee Elected as Board Governor of International Society of Cryobiology

Future Promise Salon Event Successfully Held: Yinfeng Life Extension Plan Members Engage in a Warm Dialogue on Life and the Future

"10th China Contemporary Thanatology Symposium in Macao: Yinfeng Promotes Life Education Through Technology"

The World’s First Ovarian Tissue Dual-Activation Technology Selected into the 2025 "Shandong Outstanding Achievements Report" Project

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

Professor Xu Yi from Yinfeng Cryomedicine Expert Committee Elected as Board Governor of International Society of Cryobiology

2025/12/19

According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.

Future Promise Salon Event Successfully Held: Yinfeng Life Extension Plan Members Engage in a Warm Dialogue on Life and the Future

2025/12/09

The significance of life extension lies not only in technological breakthroughs but also in the shared belief of every individual who believes in "a better future." With faith as their torch, these fellow travelers join hands, pooling their strength to stride forward together. We firmly believe that as this steadfast support converges into a powerful force, it will propel the Yinfeng Life Extension Plan to gain broader attention, inject continuous momentum into the development of cryobiomedicine, and illuminate the next chapter of human civilization.

"10th China Contemporary Thanatology Symposium in Macao: Yinfeng Promotes Life Education Through Technology"

2025/10/14

Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.

The World’s First Ovarian Tissue Dual-Activation Technology Selected into the 2025 "Shandong Outstanding Achievements Report" Project

2025/10/13

According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).

2025-10-13

→

The World’s First Ovarian Tissue Dual-Activation Technology Selected into the 2025 "Shandong Outstanding Achievements Report" Project

2025-08-29

→

Focus on Frigid Zone Medicine: Yinfeng Low - Temperature Medical Team Publishes an Important Review on Cryopreservation

Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.

2025-07-28

→

The themed life - education event for members of the Yinfeng Life Extension Program was successfully held

On July 26, 2025, the "Life · Rebirth · Harvest" themed life - education practice event co - hosted by Shandong Yinfeng Life Science Research Institute, Jinan Second Funeral Home, and Jinan Xingfu Yigong Social Work Service Center was successfully held. The event attracted the active participation of experts in the field of life education, members of the Life Extension Program, members of the "Love · Lotus Talk" Life Education Volunteer Service Team, and representatives of social workers.

2025-07-01

→

Yinfeng Life Sciences Research Institute's Cryomedicine Research Center collaborates with the Chinese Academy of Medical Sciences to launch a major brain science technology research project.

2025-05-27

→

Yinfeng Institute’s Ovarian Tissue Cryopreservation Technology Wins Shandong Refrigeration and Air Conditioning Science and Technology Award

Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.

2025-05-20

→

Developing Countries Officials Training Workshop Visits Yinfeng Biological Group to Explore Frontiers of Life Sciences

On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.